Search results
Results from the WOW.Com Content Network
For the study, which was published in JAMA Psychiatry on November 13, researchers analyzed data from about 228,000 people in Sweden with alcohol use disorder. The researchers found that people who ...
Now a new study recently published in the journal JAMA Psychiatry reports that semaglutide — the active ingredient in glucagon-like peptide-1 receptor agonist (GLP-1) medications Ozempic and ...
JAMA Psychiatry (until 2013: Archives of General Psychiatry) is a monthly peer-reviewed medical journal published by the American Medical Association. It covers research in psychiatry , mental health , behavioral sciences , and related fields. [ 1 ]
A study published in JAMA Psychiatry analyzed data from 858 participants who were diagnosed with depressive disorders. Participants were randomly assigned to receive bright light therapy alone or ...
JAMA (The Journal of the American Medical Association) is a peer-reviewed medical journal published 48 times a year by the American Medical Association. It publishes original research, reviews, and editorials covering all aspects of biomedicine .
The Journal of the American Medical Association (JAMA), along with JAMA Network Open and eleven specialty journals, compose the JAMA Network family of journals. [1] The journals share a common website, [ 2 ] archives and other means of access (such as RSS feeds), [ 3 ] have common policies on publishing and public relations, [ 4 ] and pool ...
The study, published in the journal JAMA Network Open, found that the number of new schizophrenia cases linked to cannabis use disorder, CUD, has more than doubled in Ontario, rising from 4 per ...
ADHD medication tied to 19% lower death risk. An observational study conducted in Sweden, whose results appeared in JAMA in March 2024, further emphasized the positive impact of ADHD medication on ...